MARK JABRO: Open Payments
NPI 1326058330 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,241 in 77 payments from 3 companies in 2025. Trend: 2023 $291 · 2024 $15,135 · 2025 $35,241
Speaker / faculty: $20,500Consulting: $8,050Travel & lodging: $5,435Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 67 | $34,819 |
| Novo Nordisk Inc | 5 | $216 |
| Intra-Sana Laboratories | 5 | $207 |
Products named: ZEPBOUND, RELTONE 200 MG, Wegovy, KISUNLA, Saxenda, GLYCATE.
Industry payments across CA — which companies pay providers there.
